Steven L. Cook, Chief Financial Officer of Omada Health, Inc. (OMDA), executed a sale of 6,800 shares of the company’s common stock on June 15, 2026. The transaction, valued at $117,183, was conducted under a pre-arranged 10b5-1 trading plan adopted on March 14, 2026. The shares were sold at prices ranging from $17.00 to $17.47 per share, resulting in a weighted average price of $17.2329. Following this transaction, Mr. Cook directly holds 187,209 shares of Omada Health common stock.
This sale activity occurs against a backdrop of recent positive financial developments for the company, including a first-quarter 2026 earnings surprise and an upward revision of the analyst price target by Citizens. The sale price aligns closely with the current stock price of $17.10, though InvestingPro analysis suggests the stock may be overvalued at current levels. While the company wasn’t profitable over the last twelve months, analysts predict profitability this year—one of several InvestingPro Tips available alongside a comprehensive Pro Research Report for deeper analysis.
In other recent news, Omada Health Inc. reported its financial results for the first quarter of 2026, showcasing a positive earnings surprise. The company achieved an earnings per share (EPS) of -$0.05, which was better than the forecasted -$0.08. Omada Health’s revenue reached $78 million, representing a 42% increase compared to the same period last year. These results reflect significant growth and have contributed to investor optimism.
Additionally, Citizens raised its price target for Omada Health to $21 from $18 while maintaining a Market Outperform rating. The analyst from Citizens highlighted the company’s trading range since its IPO in June 2025, noting a range of 1.3 to 6.6 times forward revenue. These developments indicate a positive outlook for Omada Health, as evidenced by the raised price target and strong financial performance.
The stock closed at $17.10 on June 15, 2026, representing a decrease of $0.23 or 1.33%. After hours trading showed the stock at $17.11, with no change. The trading range for Omada Health since its IPO in June 2025 has been between 1.3 and 6.6 times forward revenue, according to the analyst from Citizens. This information is part of a comprehensive Pro Research Report available for deeper analysis.